alexa Pharmaceutical Formulation | OMICS International
ISSN : 2153-2435
Pharmaceutica Analytica Acta

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Pharmaceutical Formulation

Sousa e Silva JP*

Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, Department of Drug Sciences, University of Porto, Rua Jorge Viterbo Ferreira, 228 4050-313 Porto, Portugal

*Corresponding Author:
Sousa e Silva JP
Laboratory of Pharmaceutical Technology
Faculty of Pharmacy, Department of Drug Sciences
University of Porto, Rua Jorge Viterbo Ferreira
228 4050-313 Porto, Portugal
E-mail: paul[email protected]

Received date: January 10, 2013; Accepted date: January 14, 2013; Published date: January 16, 2013

Citation: Sousa e Silva JP (2013) Pharmaceutical Formulation. Pharmaceut Anal Acta 4:e145. doi: 10.4172/2153-2435.1000e145

Copyright: © 2013 Sousa e Silva JP. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Pharmaceutica Analytica Acta


Pharmaceutical formulation could be simply defined as the design of dosage forms. However, this definition is too simplistic, since it does not reflect the complexity of developing pharmaceutical dosage forms. This can explain why it is easy to find references to the operation of formulation, but the definitions that describe the process are rare. Prista et al. [1], which addressed this issue, suggests that formulation could be defined as the set of operations that aim to create a physical system which contain the drug, in order to meet the quality requirements set in advance (specifications) and ensuring the maintenance of efficacy and safety characteristics of the active substance.

In the past the art of formulating had as main objective to make drug administration easier and enjoyable, but probably it always had associated, albeit incipient, the concern of stability. Currently pharmaceutical formulation, in addition to facilitate drug delivery and stability must ensure adequate bioavailability. Moreover, should enable large scale reproducibly production of medicines which comply with specification. Using preformulation as starting point, biopharmacy as support, and having as a backdrop regulatory aspects and what was defined in the project development (target product profile) pharmaceutical scientist may formulate. In practice, formulating consists in selecting the excipients, the manufacturing process, and evaluating the formulations obtained using physicochemical and pharmacotechnical tests. These tests allow selecting, optimizing and evaluating pharmaceutical preparations based on pre-established specifications. Formulation, which for many centuries was an art, begun, during the last century, to lose gradually this status in favor of a scientific –based approach, initially by controlling one factor at a time. Currently, almost all pharmaceutical technologists are aware of the disadvantages of one factor at time and recognize the advantages of statistical approach (Design of Experiments) in the formulation [2].

The concept factorial design basically consists in studying the influence of a number of factors on a response variable by varying simultaneously, but in a planned and random way (per levels), all factors. Using factorial design it is possible to evaluate the effect of each factor influencing the formulation (and possibly the interaction between factors) based on statistical analysis [3]. Factorial design may be used to select excipients and their quantities and/or conditions of the manufacturing process in preliminary or optimization studies. Partial factorial designs, which allow assessing a large number of variables by performing a relatively small number of experiments, like fractional factorial design and Plackett-Burman are used in screening studies. The Plackett-Burman design is used when only the main effects are considered significant. In this type of design (Plackett-Burman) at two levels, the number of experiments is multiple of 4 instead of being a power of 2. Full factorials are used in the optimization, where the number of variables under study tends to be lower. They have also been used artificial intelligence programs in developing formulations, such as expert systems and artificial neural networks [4]. The expert systems are computer programs that use knowledge to solve problems of inference that normally require human experts to resolve the matter. The artificial neural networks are programs that simulate biological functions of the brain such as learning.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 12080
  • [From(publication date):
    January-2013 - Jul 19, 2018]
  • Breakdown by view type
  • HTML page views : 8261
  • PDF downloads : 3819

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version